Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($25.51), $25.40 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UDynamics files for Nasdaq IPO of 5.6 million shares at $5-$7 per share
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"